Table III.
ACE gene polymorphism and the risk of sarcoidosis
| ACE gene polymorphism | Studied group | Statistical analysis | ||
|---|---|---|---|---|
| Healthy individuals (n = 242) |
Patients with sarcoidosis (n = 180) |
P χ2 |
OR 95% CI |
|
| I/I | 64 (26.5%) | 37 (20.6%) |
0.258 2.71 |
_ |
| I/D | 110 (45.5%) | 95 (52.8%) | ||
| D/D | 68 (28%) | 48 (26.6%) | ||
| I/I + I/D | 174 (72%) | 132 (73.4%) | 0.744 0.11 |
1.075 0.697–1.657 |
| D/D | 68 (28%) | 48 (26.6%) | ||
| D/D + I/D | 178 (73.5%) | 143 (79.4%) | 0.161 1.97 |
1.39 0.877–2.203 |
| I/I | 64 (26.5%) | 37 (20.6%) | ||